We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3231:TSENomura Real Estate Holdings, Inc. Analysis

Data as of 2026-06-12 - not real-time

NT$157.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Wistron Corp (3231.TW) is trading at TWD 157, comfortably above its 20‑day SMA (TWD 156.5) and well above the 50‑day SMA (TWD 145.3), signaling a short‑term bullish bias. Technical momentum is mixed, however, as the MACD line sits below its signal (5.55 vs 7.20) and the histogram is negative, hinting at possible near‑term weakness. The RSI of 51 suggests the stock is neither overbought nor oversold, while a rising volume trend supports the current price action. On the valuation side, the trailing P/E of 18.7 is far below the industry average of 36.5, and the forward P/E of 8.99 points to significant upside, with analysts targeting a mean price of TWD 203 – a 29% upside potential. The dividend yield of 3.61% and a payout ratio of 45% make the stock attractive for income seekers, though negative operating and free cash flow raise questions about long‑term sustainability. Financially, the company carries a high debt load (Debt‑to‑Equity 167%) and a sizable max drawdown of –22.7%, contributing to elevated risk despite a beta under 1. Geopolitical exposure to Taiwan and export markets adds a layer of geographic risk, while the high 30‑day volatility (68%) underscores price swings. Overall, the blend of undervalued metrics, solid dividend income, and strong upside targets makes Wistron a compelling candidate for medium‑term investors, but caution is warranted given leverage and cash‑flow constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish SMA alignment
  • Bearish MACD divergence
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E relative to industry
  • Attractive dividend yield
  • Analyst price target implying ~30% upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt‑to‑equity ratio
  • Negative operating cash flow
  • Sustained demand for technology hardware

Key Metrics & Analysis

Financial Health

Revenue Growth144.30%
Profit Margin1.18%
P/E Ratio18.7
ROE27.22%
ROA5.37%
Debt/Equity167.38
P/B Ratio2.6
Op. Cash FlowNT$-219190771712
Free Cash FlowNT$-281941082112
Industry P/E36.5

Technical Analysis

TrendBullish
RSI51.1
SupportNT$132.00
ResistanceNT$201.00
MA 20NT$156.53
MA 50NT$145.31
MA 200NT$137.40
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Target PriceNT$203.07
Upside/Downside29.34%
GradeUndervalued
TypeBlend
Dividend Yield3.61%

Risk Assessment

Beta0.91
Volatility68.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.